At a glance
ClinicalIndex Comparison RecordN/ACompleted· 26 enrolled
Drug / intervention
Medroxyprogesterone acetatedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pharmacokinetics of Subcutaneous Depot Medroxyprogesterone Acetate Injected in the Upper Arm
In Brief
A clinical study evaluating Medroxyprogesterone acetate for Contraception. Completed, enrolled 26 participants across 1 site.
Detailed Summary
A single-arm trial to demonstrate that Depo-SubQ Provera injected in the upper arm is adequate for effective contraception
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsContraception
CountriesUnited States
CollaboratorsEastern Virginia Medical School
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2010
First PostedJun 2010
Primary CompletionOct 2011
Study CompletionOct 2012
TodayJul 2026
First PostedJun 14, 2010
Enrollment StartMay 1, 2010
Primary CompletionOct 1, 2011
Study CompletionOct 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 16.1 years ago
Interventions
Medroxyprogesterone acetatedrug
Injectable hormonal contraceptive